全文获取类型
收费全文 | 127691篇 |
免费 | 9485篇 |
国内免费 | 457篇 |
专业分类
耳鼻咽喉 | 1344篇 |
儿科学 | 3164篇 |
妇产科学 | 2092篇 |
基础医学 | 18223篇 |
口腔科学 | 2523篇 |
临床医学 | 12823篇 |
内科学 | 27859篇 |
皮肤病学 | 2458篇 |
神经病学 | 13087篇 |
特种医学 | 4969篇 |
外国民族医学 | 9篇 |
外科学 | 18335篇 |
综合类 | 1519篇 |
一般理论 | 101篇 |
预防医学 | 9816篇 |
眼科学 | 2208篇 |
药学 | 8485篇 |
1篇 | |
中国医学 | 166篇 |
肿瘤学 | 8451篇 |
出版年
2023年 | 637篇 |
2022年 | 1213篇 |
2021年 | 2462篇 |
2020年 | 1541篇 |
2019年 | 2323篇 |
2018年 | 2828篇 |
2017年 | 2066篇 |
2016年 | 2477篇 |
2015年 | 2876篇 |
2014年 | 3875篇 |
2013年 | 5212篇 |
2012年 | 8009篇 |
2011年 | 8222篇 |
2010年 | 4870篇 |
2009年 | 4546篇 |
2008年 | 7383篇 |
2007年 | 8023篇 |
2006年 | 7558篇 |
2005年 | 7591篇 |
2004年 | 7055篇 |
2003年 | 6401篇 |
2002年 | 6344篇 |
2001年 | 2257篇 |
2000年 | 2104篇 |
1999年 | 2039篇 |
1998年 | 1576篇 |
1997年 | 1318篇 |
1996年 | 1095篇 |
1995年 | 1087篇 |
1994年 | 942篇 |
1993年 | 862篇 |
1992年 | 1457篇 |
1991年 | 1355篇 |
1990年 | 1270篇 |
1989年 | 1210篇 |
1988年 | 1071篇 |
1987年 | 1014篇 |
1986年 | 1055篇 |
1985年 | 1039篇 |
1984年 | 874篇 |
1983年 | 776篇 |
1982年 | 770篇 |
1981年 | 678篇 |
1980年 | 577篇 |
1979年 | 652篇 |
1978年 | 538篇 |
1977年 | 501篇 |
1975年 | 435篇 |
1974年 | 457篇 |
1973年 | 437篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Dongbing Lai Emma C. Johnson Sarah Colbert Gayathri Pandey Grace Chan Lance Bauer Meredith W. Francis Victor Hesselbrock Chella Kamarajan John Kramer Weipeng Kuang Sally Kuo Samuel Kuperman Yunlong Liu Vivia McCutcheon Zhiping Pang Martin H. Plawecki Marc Schuckit Jay Tischfield Leah Wetherill Yong Zang Howard J. Edenberg Bernice Porjesz Arpana Agrawal Tatiana Foroud 《Alcoholism, clinical and experimental research》2022,46(3):374-383
2.
3.
Rizzo Manglio Miguel Bluthgen Mara Virginia Recondo Gonzalo Naveira Martin Perfetti Aldo Rizzi Florencia Kuzminin Alejandro Faura Victoria Cerini Matas Videla Alejandro Silva Carlos Lupinacci Lorena Minatta Nicols 《International journal of clinical oncology / Japan Society of Clinical Oncology》2021,26(6):1057-1064
International Journal of Clinical Oncology - Immune-checkpoint inhibitors (ICIs) are standard treatments for metastatic non-small cell lung cancer (NSCLC). Patients with poor performance status... 相似文献
4.
5.
Rebecca Martin 《Early child development and care》2019,189(4):683-696
The current study explored the influence of three methods of parental emotion discourse (structured story-telling, reminiscing, and picture book) and their relation to preschoolers’ emotion understanding. Thirty-seven families participated in the study. Analyses showed that the structured story-telling method produced more emotion words, was high in unique emotion words, and was high for both emotion labelling and explanations. All three methods showed some potential to predict preschooler’s emotion understanding. Structured story-telling was best at predicting role-taking, while reminiscing and the picture book both were better at predicting situation knowledge. Additional studies are needed to further explore the influence of different methods of assessing emotion discourse to enhance validity and reliability of research in this field. 相似文献
6.
Martin R. Späth Malte P. Bartram Nicolàs Palacio-Escat K. Johanna R. Hoyer Cedric Debes Fatih Demir Christina B. Schroeter Amrei M. Mandel Franziska Grundmann Giuliano Ciarimboli Andreas Beyer Jayachandran N. Kizhakkedathu Susanne Brodesser Heike Göbel Jan U. Becker Thomas Benzing Bernhard Schermer Martin Höhne Markus M. Rinschen 《Kidney international》2019,95(2):333-349
7.
Notfall + Rettungsmedizin - 相似文献
8.
Whitney S. Brandt Wanpu Yan Jian Zhou Kay See Tan Joseph Montecalvo Bernard J. Park Prasad S. Adusumilli James Huang Matthew J. Bott Valerie W. Rusch Daniela Molena William D. Travis Mark G. Kris Jamie E. Chaft David R. Jones 《The Journal of thoracic and cardiovascular surgery》2019,157(2):743-753.e3
Objective
Comparative survival between neoadjuvant chemotherapy and adjuvant chemotherapy for patients with cT2-4N0-1M0 non–small cell lung cancer has not been extensively studied.Methods
Patients with cT2-4N0-1M0 non–small cell lung cancer who received platinum-based chemotherapy were retrospectively identified. Exclusion criteria included stage IV disease, induction radiotherapy, and targeted therapy. The primary end point was disease-free survival. Secondary end points were overall survival, chemotherapy tolerance, and ability of Response Evaluation Criteria In Solid Tumors response to predict survival. Survival was estimated using the Kaplan–Meier method, compared using the log-rank test and Cox proportional hazards models, and stratified using matched pairs after propensity score matching.Results
In total, 330 patients met the inclusion criteria (n = 92/group after propensity-score matching; median follow-up, 42 months). Five-year disease-free survival was 49% (95% confidence interval, 39-61) for neoadjuvant chemotherapy versus 48% (95% confidence interval, 38-61) for adjuvant chemotherapy (P = .70). On multivariable analysis, disease-free survival was not associated with neoadjuvant chemotherapy or adjuvant chemotherapy (hazard ratio, 1.1; 95% confidence interval, 0.64-1.90; P = .737), nor was overall survival (hazard ratio, 1.21; 95% confidence interval, 0.63-2.30; P = .572). The neoadjuvant chemotherapy group was more likely to receive full doses and cycles of chemotherapy (P = .014/0.005) and had fewer grade 3 or greater toxicities (P = .001). Response Evaluation Criteria In Solid Tumors response to neoadjuvant chemotherapy was associated with disease-free survival (P = .035); 15% of patients receiving neoadjuvant chemotherapy (14/92) had a major pathologic response.Conclusions
Timing of chemotherapy, before or after surgery, is not associated with an improvement in overall or disease-free survival among patients with cT2-4N0-1M0 non–small cell lung cancer who undergo complete surgical resection. 相似文献9.
10.
Interprofessional collaboration and communication in nursing homes: a qualitative exploration of problems in medical care for nursing home residents – study protocol 下载免费PDF全文